NCT02700711View on ClinicalTrials.gov

Methylphenidate-Duloxetine Combinations for Cocaine Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Cocaine Use Disorder
Interventions
DRUG

Methylphenidate

The pharmacodynamic effects of methylphenidate maintenance will be determined during maintenance on placebo and duloxetine.

DRUG

Placebo

The pharmacodynamic effects of placebo will be determined during maintenance on placebo and duloxetine.

DRUG

Duloxetine

The pharmacodynamic effects of duloxetine will be determined during maintenance on placebo and methylphenidate

Trial Locations (1)

40536

University of Kentucky Medical Center, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Kentucky

OTHER

NCT02700711 - Methylphenidate-Duloxetine Combinations for Cocaine Dependence | Biotech Hunter | Biotech Hunter